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Abstract
Background: With malaria drug resistance increasing in prevalence and severity, new technologies are needed to
aid and improve the accuracy and clinical relevance of laboratory or field testing for malaria drug resistance. This
study presents a method based on simple and reagentless spectroscopic measurements coupled with
comprehensive spectral interpretation analysis that provides valuable quantitative information on the
morphological and compositional responses of Plasmodium falciparum and infected red blood cells (IRBCs) to
anti-malarial treatment.
Methods: The changes in the size, internal structure, nucleotide and haemozoin composition of the parasites as
well as the morphology (size and shape) and haemoglobin composition of the IRBCs treated with
dihydroartemisinin (DHA) and mefloquine (MFQ) were investigated using a spectral interpretation analysis.
Results: DHA treatment reduced the sizes of the parasites and their structural organelles. The haemoglobin
composition of the host IRBCs determined from spectroscopic analysis changed negligibly following DHA
treatment. MFQ treated parasites grew to the same size as those from parallel non-treated cultures but lacked
haemozoin. Lesser deformation of the cell shape and no haemoglobin depletion were detected for the IRBCs of
MFQ treated cultures.
Conclusions: The spectroscopic analysis method proved to be sensitive for recognition of the effects of
anti-malarial treatment on the structure and composition of the parasites and IRBCs. The method can have
significant potential for research and clinical applications such as evaluating patient specimens for drug action, drug
effects or for therapeutic monitoring.
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Background
Microscopy has long been the “gold standard” as a tool
for the research based characterization of malaria infected
red blood cells (IRBCs) and for the detection of malaria
parasites in the field [1-5]. Because this technique is
constrained by substantial technical and economic hurdles
such as operator training, time needed to perform a test,
and labor intensiveness, there is an ongoing search for
alternatives. Immunochromatography-based rapid diag-
nostic tests have gained widespread popularity because of
ease-of-use but often suffer from high variability, poor
sensitivity for mixed infections of Plasmodium species
other than Plasmodium falciparum, extensive requirements
for reagent quality control [2,3,6]. Techniques based on
polymerase chain reaction (PCR) offer superior sensitivity,
ability to detect mixed species infection and the ability to
differentiate among four species of Plasmodium but they
require considerable cost of equipment as well as storage
and maintenance requirements for reagents [2,4]. Quanti-
tative PCR has been repeatedly demonstrated to be more
accurate than microscopy for the detection of malaria at
very low levels of parasitaemia [7,8] and it disagrees with
microscopy for parasitaemia counts at higher parasitaemia
levels [8]. It is not straightforward and requires complicated
analysis to assess the sensitivity of the malaria parasites to
anti-malarials using immunochromatography or molecular
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methods [9-11] and is time-consuming when using classical
in vivo studies [12].
UV-visible spectroscopy that explores spectral changes
in the infected red blood cells is a new tool in malaria
diagnostics that overcome most of the disadvantages of
the current malaria diagnostics methods by being rapid,
sensitive and quantitative. Spectroscopic and light
scattering techniques have been a subject of continu-
ous interest since these non-destructive measurements
provide substantial information on the physical, chem-
ical, and physiological character of cells and, therefore,
can potentially detect and identify changes in cells that
are indicative of diseases. For instance, flow cytometry and
commercial haematology analyzers utilizing abnormalities
in the multiple-angle polarized scattering plots have dem-
onstrated potential for the detection of malaria parasites
in blood with reported sensitivities of ≥ 95% in samples
with >100 parasites/μl and is in compliance with WHO
malaria-diagnostic guidelines [1,13].
Given that the asexual stages of the malaria parasites
occur inside red blood cells (RBCs), assessment of the
changes in the red blood cell (RBC) properties is a valuable
approach for infection detection and characterization. This
prominent component of blood has long been attractive to
the spectroscopic investigations as a light scatterer with a
homogeneous body and the distinct spectroscopic features
of its main constituent, haemoglobin. The IRBC morph-
ology and composition appreciably affect the spectra with
the progression of the intraerythrocytic development of
malaria parasites. Even though the size and shape of an
IRBC at the ring stage remain the same as those of non-
infected RBCs [14], the parasite with its parasitophorus
vacuole occupies 5-15% of the host volume [15-17]. The
parasite occupies about one third of the host IRBC by the
trophozoite stage [16,18] and more than a half of the host
volume through the subsequent schizont stage [15,18,19].
This growth is accompanied with the loss of shape,
swelling, and formation of protrusions on the IRBC
surface [18,20,21]. The parasite continuously uptakes
haemoglobin from the host cytosol and converts it into
haemozoin deposited into the parasite’s digestive vacuole
[22-24]. Haemoglobin depletion of the host and haemozoin
build up in the parasite’s vacuole progress with the para-
site’s development and become the greatest at the schizont
stage [22-24]. It has been demonstrated for different
intraerythrocytic life stages of P. falciparum that the
UV-visible spectroscopy can track these changes [25].
Since anti-malarial treatment leads to the morphological
and/or compositional changes in the parasites, in this study
it was hypothesized that anti-malarial effect can be
captured by UV-visible measurements. The objectives
of this study were to examine the hypothesis with the
experimentally acquired data using dihydroartemisinin
(DHA) and mefloquine (MFQ), to effectively obtain
quantitative measurements of the morphological parame-
ters, haemoglobin composition of the IRBCs and compos-
ition of the parasites following the treatment, and to show
the sensitivity of the method for the recognition of the
effects of anti-malarial treatment. To achieve the objectives,
simultaneous measurements of the absorption and forward
scattering in the UV-visible-NIR portion of the electromag-
netic spectrum were coupled with a spectral interpretation
model based on an ellipsoidal approximation to the multi-
layered Mie theory. The parameters such as the size,
nucleotide and haemozoin composition of the parasites as
well as the size, shape and haemoglobin composition
of the IRBCs could serve as the determining factors of
the susceptibility or resistance of the parasite.
Methods
Sample preparation
In vitro cultures of the W2 strain P. falciparum were
grown at 4% hematocrit in RPMI media to 6-14% para-
sitaemia following the standard method [26]. Cultures
were synchronized with both D-sorbitol and incubation
temperature cycling of 17°C and 40°C to achieve a high
concentration of ring stage parasites. Five independent
experiments were conducted. In each experiment, cultures
were prepared by either splitting a parent culture into
subcultures, or growth of two or three parallel cultures.
One subculture or parallel culture was set as a control
(no drug exposure) and others were treated with either
mefloquine (MFQ) or dihydroartemisinin (DHA). The
exposure concentration of each drug was 1,500 ng/mL
(7.5 μl of 1 mg/ml MFQ or DHA solution was added to
a 5 ml culture). The experiments always started with all
cultures being at the ring stage. The parasite extraction
from IRBCs was performed by saponin lysis as previously
described [14]. Briefly, 1 ml of 0.1% saponin solution in
PBS was added to 0.5 ml of approximately 50% haematocrit
RBC suspension. The mixture was incubated at 37°C with
constant agitation for 15 minutes. Then, it was centrifuged
at 13,000 rpm for 1 min and the pellet was resuspended in
PBS. The procedure was repeated 3–4 times to remove the
dissolved haemoglobin and the RBC membrane fragments.
Visible microscopy inspection was performed to confirm
the integrity of the extracted parasites.
Spectrophotometric measurements
To measure the UV-visible-NIR spectra of IRBC cultures,
0.5 ml of each culture was centrifuged at 13,000 rpm for
30 seconds, growth media was aspired, and the cells were
suspended in 1 ml of phosphate buffered saline (PBS). The
procedure was repeated 3–4 times until the supernatant
was clear of the growth media. The UV-visible-NIR
spectra were recorded using a diode array spectrometer
(Agilent 8453 Santa Clara, CA) having an acceptance
angle smaller than 2° at room temperature using a 1 cm
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pathlength cuvette. The measurements were conducted
with an acquisition time of 0.5 sec, signal to noise ratio
greater than 1000, and 1 nm wavelength resolution. Prior
to recording a sample spectrum the spectrometer was
zeroed to account for any stray light. The background
spectrum was taken using a sample from the same PBS
batch utilized in the preparation of the RBCs suspensions.
Twenty microlitres of prepared RBC suspension was added
to 2 ml of PBS in a quartz cuvette and inverted to ensure
homogeneous distribution of RBCs in the cuvette. For each
culture sample, 5–8 replicate spectral measurements were
taken. The spectral measurements were taken at 10–11,
15–17, and 22 (for MFQ treated and control cultures) hrs
post treatment.
Spectral interpretation analysis
The structure of the spectral interpretation model for
IRBCs was described in detail in Serebrennikova et al. [25].
In brief, the model included a three-layer Mie geometry
(i.e., a sphere having three concentric layers) to account
for changes in the refractive indices of the IRBC cytosol
and the parasite’s cytoplasm and organelles. The model
incorporated an ellipsoidal approximation to Mie theory
to account for the effects of the RBC orientation and
non-spherical shape. It has been recently demonstrated
that this approximation can accurately predict the spec-
tral features of oriented composite ellipsoids [27]. The
ellipsoidal approximation to the RBC shape is quantita-
tively suitable for the prediction of light attenuation by
RBCs in the forward direction [28]. According to the
model the measured optical density was theoretically
predicted as a weighted sum of the extinctions of orien-
tation populations:
τ λð Þcalc ¼ NpL
X
ωi Ai=4ð ÞQext;i ð1Þ
where τ(λ) calc is the predicted total optical density at
given wavelength λ, Np is the total number density of
cells, L is the pathlength, ω1 is the weight fraction of
the ith orientation, Ai and Qext,i are the projected area and
extinction, respectively, of the cells at the ith orientation.
The extinction Qext of each IRBC orientation was, in turn,
computed as weighted sum of the extinctions of three
structural groups (Figure 1):
Qext;i ¼ ωDVQext;DV þ ωNUQext;NU þ ωORGQext;ORG
ð2Þ
Each structural group was modelled as a three-layer
structure such that the outer layer was the IRBC cytosol,
the intermediate layer was the parasite’s cytoplasm,
and the core was a parasite’s structural element. Three
structural elements were suggested by the available infor-
mation on the morphological structure of P. falciparum
cells [15]. Those were digestive vacuole (DV) containing
haemozoin, nucleus (NU) containing nucleic acid that
provides distinct spectral contribution, and the third
structural element was the population of other protozoan
organelles. This “average” organelle (ORG) was modelled
using the average refractive index of non-chromophoric
molecules of biological cells [29]. Validated approximation
of additivity of the spectral contributions from the struc-
tural groups [25,29] was used. The extinction of each
structural group was a function of the size parameters and
refractive indices of the layers. The size parameter of each
layer (χ) was defined as:
χ ¼ 2πn0DMIE=λ ð3Þ
where n0 is the refractive index of the medium and DMIE is
the diameter. In the case of the outer layer (i.e., RBC cytosol)
DMIE denotes the equivalent sphere diameter of the ellipsoid
computed according to [30] as:
DMIE ¼ a=g ð4Þ
g ¼ cos2ψ þ cos2ξ þ r2 sin2ξ  sin2ψ 1=2 ð5Þ
where r= a/c is the ratio of the symmetry axis a to minor
axis c of the ellipsoid and ψ and ξ are the rotation angles
of the ellipsoid’s x-z and y-z planes with respect to the
direction of the incident beam. The real n and imaginary
k parts of the complex refractive index of the lth layer
were computed as weighted sums of the refractive indices
of its compositional constituents:
kl ¼ ∑υljkj ð6Þ
nl ¼ ∑υljnj ð7Þ
where υij is the weight fraction of the j
th compositional con-
stituent in the lth layer (Table 1). The outer layer was mod-
elled to be composed of haemoglobin and water. The
intermediate layer (i.e. parasite cytoplasm) was modelled to
be composed of water and non-absorbing macromolecules
[29]. The core elements were modelled as following: nu-
cleus was composed of nucleic acid, non-absorbing macro-
molecules, and water; digestive vacuole was composed of
water and haemozoin [25]; and the “average” organelle was
composed of water and non-absorbing macromolecules.
The refractive index of nucleic acid was constructed
from those of the purine and pyrimidine bases [29] assum-
ing G + C fraction of 0.2 for P. falciparum [31].
The interpretation procedure consisted of the predic-
tion of the measured spectra as functions of the model
parameters and subsequent comparison of the predicted
and measured spectra using an iterative least squares
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minimization procedure. The residual sum of squares
(RSSQ) was calculated as:
RSSQ ¼ 1=Mð Þ∑ τ λð Þmeas;m−τ λð Þcalc;m
 2
ð8Þ
where M = 651 and corresponds to the 250–900 nm
wavelength range and 1 nm wavelength resolution. Model
parameters were iterated until convergence (i.e., relative
changes in RSSQ were less than 10-5) using a Nelder-Meade
downhill simplex optimization algorithm and variable
transformation techniques [14,25].
The outputs of the interpretation analysis were used to
reconstruct the measured spectra of IRBCs. In order to
eliminate the orientation effect [25] and, therefore, to
directly compare the effects of the structural and compos-
itional differences, the IRBC spectra were reconstructed
with the same orientation parameters. The interpretation
of the measured UV-visible-NIR spectra of P. falciparum
cells extracted from IRBCs was conducted using two-layer
Mie theory as described in detail in [14].
Results and discussion
Untreated parasites
The average reconstructed spectra of non-infected healthy
RBCs (H), control IRBCs (IC), MFQ treated IRBCs (IM),
and DHA treated IRBCs (ID) at 10–11 hrs post treatment
are contrasted in Figure 2. Significant differences in
the spectral features could be noted. Comparison of
non-infected RBCs and IRBC controls revealed spectral
changes that were due to the structural and compositional
alterations to IRBCs caused by intraerythrocytic develop-
ment of parasites. The interpretation models allowed the
calculation of parameters relating to the morphology and
haemoglobin composition of IRBCs as well as the size,
structure, nucleotide and haemozoin composition of para-
sites from the measured spectra of IRBCs and extracted
parasites. These structural and compositional parameters of
the parasites in control cultures are given in Table 2.
Figure 3 compares their measured and reconstructed spec-
tra as well as the spectral contributions of the modelled
structural groups. The structural and compositional param-
eters of IRBC control cultures are given in Table 3.
Comparison between the parameters of control parasites
obtained at 10–11 and 15–22 hrs revealed progressive
changes in the sizes of the cells and organelles as well as
haemozoin and nucleotide content of the cells indicating
growth and metabolic activity. For instance, the estimated
cell volume for P. falciparum increased from 16 μm3 at
10–11 hrs to 20–22 μm3 at 15–22 hrs. These values showed
a transition from the ring to trophozoite stages paralleling
other reports of cell volumes (10 ± 5 μm3 and 30 ± 10 μm3)
for the ring and trophozoite stages, respectively [15,17]. The
digestive vacuole volume has been reported to range from
4 μm3 at the early trophozoite stage [15,24] to 9–11 μm3 at
later developmental stages [20]. The DV volumes estimated
in this study were in good agreement with published data
and also suggested early trophozoite stage at 10–11 hrs and
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Figure 1 Schematics of the P. falciparum infected RBC model. IRBC was approximated as a weighted sum of three structural groups each
having three concentric layers. The outer layer was IRBC cytosol, the middle layer (dashed line) was the parasite’s cytoplasm and the core was
either digestive vacuole (DV), nucleus (NU), or organelles (ORG).
Figure 2 Reconstructed spectra of non-infected healthy RBCs
(H), control IRBCs (IC), MFQ treated IRBCs (IM), and DHA
treated IRBCs (ID) at 10–11 hrs post treatment.
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controls. Published micrographs of P. falciparum suggest
that the nucleus occupies about 10-25% of the cell volume
[15] and are in agreement with nucleus volumes obtained
in this study (2.2-2.8 μm3) (Table 2). The amount of total
nucleotide in control parasites (Table 2) was in agreement
with our previous estimates made for P. falciparum
trophozoite stage [14]. The amounts of haemozoin
were 0.15 pg/cell and 0.27-0.3 pg/cell at 10–11 hrs and
15–22 hrs, respectively, for the controls. These values also
corresponded well to the early and and mid-trophozoite
stages of P. falciparum [23,24].
Even though control IRBCs retained the same volume
as non-infected RBCs at 10–11 hrs, the cell aspect ratio
(i.e., the ratio of the width to length) increased indicating
changes in the cell shape (Table 3). The haemoglobin
content of control IRBCs was also reduced due to its up-
take by the parasites. The volume and aspect ratio of
control IRBCs continued to increase whereas haemoglo-
bin content continued to decrease from the 10–11 to
15–17 and to 22 hrs measurements in response to the
intraerythrocytic growth of P. falciparum (Table 3). The
changes in the aspect ratio indicated swelling of IRBCs;
IRBC swelling has been previously demonstrated to occur
in response to the parasite growth through trophozoite
stage [20,32,33].
Haemoglobin losses from the IRBC cytosol to the
parasite were 15% at 10–11 hrs, 20% at 15–17 hrs, and
up to 30% at 22 hrs. These values were in agreement
with those from other studies utilizing other approaches
such as refractive index mapping and colorimetric iron
determination. These reports indicate 5-10% and 40-60%
haemoglobin depletion from the host at the ring and
trophozoite stages, respectively [17,23]. Using the estimated
values of the IRBCs’ MCH (Table 3) and haemozoin
amount accumulated by parasites (Table 2), total iron of
IRBCs was computed and expressed it as MCHI (Table 3).
These values were in good agreement with the MCH values
of non-infected RBCs indicating no net loss of iron from
Table 2 Structural and compositional parameters of
P. falciparum obtained through interpretation of the
measured UV-visible-NIR spectra of control IRBCs and
parasites extracted from the host IRBCs
Paramer 10-11 hrs 15-17 hrs 22 hrs
Average cell volume (fl) 16.0 ± 0.7 20.7 ± 0.4 22.4 ± 1.9
DV volume (fl) 3.9 ± 0.2 5.4 ± 0.2 6.0 ± 0.2
NU volume (fl) 2.8 ± 0.4 2.7 ± 0.5 2.8 ± 0.3
HZ (pg/cell) 0.15 ± 0.03 0.28 ± 0.04 0.27 ± 0.01
Nucleotides (fg/cell) 45 ± 12 141 ± 30 120 ± 21
Figure 3 Interpretation of the spectra of P. falciparum parasites extracted from IRBCs at 15–17 hrs post treatment: (A) controls,
(B) DHA treated, (C) MFQ treated. The measured spectra (τmeas), corresponding reconstructed spectra (τcalc), and predicted spectral contribution
from the nucleus (τNU), organelles (τORG), and digestive vacuole (τDV) structural components are compared in each subplot. σres denotes the
difference between the measured and predicted spectra.
Table 3 Structural and compositional parameters of
non-infected healthy RBCs and control IRBCs obtained




10-11 hrs 15-17 hrs 22 hrs
RBC volume (μm3) 83.1 ± 0.7 85.6 ± 1.0 87.8 ± 1.4 99.6 ± 1.8
RBC length (μm) 8.45 ± 0.03 8.45 ± 0.03 8.26 ± 0.05 7.95 ± 0.06
RBC width (μm) 2.22 ± 0.02 2.29 ± 0.02 2.47 ± 0.06 2.98 ± 0.08
MCHC (g ml-1) 30.4 ± 0.5 32.0 ± 0.0 28.3 ± 0.6 24.0 ± 0.1
MCH (pg cell-1) 25.5 ± 0.6 21.6 ± 1.0 20.0 ± 0.7 18.2 ± 0.5
MCHI (pg cell
-1) - 25.7 ± 0.6 25.1 ± 0.6 25.7 ± 0.7
MCHC mean corpuscular haemoglobin concentration,
MCH mean corpuscular haemoglobin amount per cell,
MCHCI estimated initial MCH of IRBCs.
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IRBCs. No haemoglobin leakage from IRBCs despite para-
site activity has been previously suggested [23].
Mefloquine studies
The sensitivity to the drug treatment at 10–11 hrs could
be appreciated when the spectra of MFQ and DHA treated
IRBCs are compared to those of the controls (Figure 4).
The spectral changes became even more pronounced at
the subsequent 15–17 hrs measurements (Figure 4).
The structural and compositional parameters of MFQ
treated parasites obtained with the interpretation model are
summarized in Table 4. The structural and compositional
parameters of IRBCs are given in Table 5. Comparison
between the estimated parameters of control (Table 2)
and MFQ treated (Table 4) parasites reveals that both
treated and control parasites synchronously grew in size
and no significant differences in the cell volumes between
the two can be noted at any measurement time point.
However, the DV volume values of MFQ treated parasites,
6.7-8.5 μm3 (Table 4), were nearly two-fold larger than
those of controls, 3.9-6.0 μm3 (Table 2). The swelling of the
parasite’s DV has been reported as one of the MFQ effects
on the parasite morphology [34]. Remarkably, cellular
haemozoin levels for MFQ treated parasites, 0.03-0.04 pg
(Table 4), were substantially reduced compared to that
of controls, 0.15-0.28 pg (Table 2). This difference be-
came more pronounced in the 15–22 hrs measuments.
Although nucleus volume appeared to be unaffected by
MFQ treatment, the estimated amount of total nucleo-
tides per cell for MFQ treated parasites was only about
a half of that for the controls (Tables 2 and 4).
Although the cell size of MFQ treated parasites increased
between the 10–11 and 15–22 hrs measurements, lack of
continuous haemozoin production and lower total nucleo-
tide levels suggest reduced metabolic activity compared to
that of the controls. The differences in these values between
control and MFQ treated parasites are already apparent at
10–11 hrs measurements (Tables 2 and 4). A comparison
between the measured spectra of control and MFQ treated
parasites also reveals the expected absence of a haemozoin
peak at 650 nm [15] (Figure 3). The greater contribution of
the DV spectral features to the reconstructed spectrum of
MFQ treated parasites was also apparent in Figure 3.
Since MFQ treated parasites stopped producing
haemozoin, the host IRBCs were not as depleted of
their haemoglobin content as the IRBC controls. For
MFQ treated IRBCs haemoglobin depletion was only
3% at all measurement time points. Even though MFQ
treated parasites did not show haemozoin production,
the size of MFQ treated IRBCs continued to increase
with parasite growth as that of control IRBCs. Yet, the
volume gained by MFQ treated IRBCs, i.e. the difference
between the IRBC volume and non-infected RBC volume,
was less than the parasite volume at any given time point.
For instance, at 10–11 hrs the volume increase was 2 μm3
whereas the parasite volume was 16 μm3 and at 22 hrs the
volume increase was 14 μm3 whereas the parasite volume
was 20 μm3. In non-treated cultures, the parasites would
have removed the excessive haemoglobin to reduce the
IRBC volume gain and, therefore, to support the IRBC
osmotic balance and integrity and to prevent the IRBC
rupture. The results from MFQ treatment suggested
that the integrity of MFQ treated IRBCs was still
maintained by the parasites. They could have done it, for
Figure 4 Reconstructed spectra of non-infected healthy RBCs (H), control IRBCs (IC), MFQ treated IRBCs (IM), and DHA treated IRBCs
(ID) at 15–17 hrs post-reatment.
Table 4 Structural and compositional parameters of
P. falciparum obtained through interpretation of the
measured UV-visible-NIR spectra of MFQ treated IRBCs
and parasites extracted from IRBCs
Paramer 10-11 hrs 15-17 hrs 22 hrs
Average cell volume (fl) 15.6 ± 0.3 21.7 ± 0.9 20.4 ± 1.6
DV volume (fl) 6.7 ± 0.3 7.6 ± 0.3 8.5 ± 0.9
NU volume (fl) 2.1 ± 0.1 2.2 ± 0.4 3.4 ± 0.2
HZ (pg/cell) 0.03 ± 0.01 0.03 ± 0.01 0.04 ± 0.01
Nucleotides (fg/cell) 26 ± 13 64 ± 3 84 ± 11
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instance, by removing the excessive water from the host
IRBC cytosol. This suggestion is supported by the higher
water to haemoglobin removal ratio calculated for treated
IRBCs (~4) compared to that for non-treated IRBCs (~2).
The spectra of MFQ treated IRBCs differred dramatically
from those of control IRBCs at all measurement time
points (Figures 2 and 3). The dominant cause of this dis-
tinction was the greater refractive index values of MFQ
treated IRBC which have a greater haemoglobin content
compared to that of non-treated IRBCs.
Dihydroartemisinin studies
It has been reported that oxidative stress caused by DHA
actually kills malaria parasites inside IRBCs [35]. Here we
examine what it meant in terms of the changes in the
structure and composition of parasites and the effects
of those changes on the spectral features of DHA treated
IRBCs. The structural and compositional parameters of
DHA treated parasites obtained through interpretation of
the spectra measured at 10–11 and 15–17 hrs are sum-
marized in Table 6. The structural and compositional
parameters of DHA treated IRBCs are given in Table 7.
All parameters estimated for DHA treated parasites were
already different from those of the controls at 10–11 hrs
post treatment. The cell size and organelle volumes were
about 30% lower for DHA treated parasites than those for
the controls. Similarly to MFQ treated parasites, DHA
treated parasites did not accumulate haemozoin. The total
nucleotide values for DHA treated parasites were con-
siderably lower than those for the controls and MFQ
treated parasites. The differences were already dramatic at
10–11 hrs and increased at the next measurement time
point. All parameter values estimated for DHA treated
parasites remained fairly unchanged between the 10–11
and 15–17 hrs measurements. This consistency suggests
no parasite growth between measurements; therefore,
DHA treated parasites were not alive by the 10–11 hrs
measurement and the structural and compositional charac-
teristics captured reflected those of dead cells. The spectral
features of DHA treated parasites were distinguished
from those of the controls and MFQ treated parasites
by the steeper slope indicative of the smaller cell size
and the reduced peak at 650 nm indicative of the smaller
haemozoin content (Figure 3).
Similarly to MFQ treatment, haemoglobin depletion of
DHA treated IRBCs was significantly reduced compared to
that of IRBC controls. DHA treated IRBCs were depleted
by only 5% in haemoglobin content at 10–11 hrs and
remained such at 15–17 hrs. The spectral interpretation
analysis showed that DHA treated IRBCs increased in
volume from the 10–11 hrs to 15–17 hrs measurements
(Table 7). Since the parasite size did not increase between
the measurements and haemoglobin content remained
the same, this volume gain could be attributed to the in-
flux of water into DHA treated IRBCs. This allowed DHA
treated IRBCs to regain their initial MCHC value that was
disturbed by the parasite invasion (Table 7). Such measure
resulted in the reduced refractive index values of DHA
treated IRBCs compared to MFQ treated IRBCs. The
refractive index of the cells has a pronounced influence on
the spectral features. The refractive indices of control
IRBCs and DHA treated IRBCs were practically the same
due to similar MCHC values at 10–11 hrs measurement
(Tables 3 and 7). In addition, given the close sizes of IRBCs
and parasites between controls and DHA treated cultures,
the spectral features of control and DHA treated IRBCs
overlapped above 400 nm at 10–11 hrs post treatment
(Figure 2). However, subsequent changes in the refractive
index of control IRBCs attributable to the parasite growth
Table 5 Structural and compositional parameters of IRBCs
obtained through interpretation of the measured
UV-visible-NIR spectra of MFQ treated cultures
Parameter 10-11 hrs 15-17 hrs 22 hrs
RBC volume (μm3) 85.0 ± 0.9 85.1 ± 1.2 97.3 ± 1.0
RBC length (μm) 8.41 ± 0.07 8.31 ± 0.02 8.15 ± 0.01
RBC width (μm) 2.30 ± 0.4 2.36 ± 0.04 2.88 ± 0.04
MCHC (g ml-1) 35.0 ± 1.0 38.0 ± 0.1 32.0 ± 0.1
MCH (pg cell-1) 24.4 ± 0.4 24.0 ± 0.5 24.4 ± 0.5
MCHI (pg cell
-1) 25.2 ± 0.2 24.7 ± 0.4 25.5 ± 0.3
Table 6 Structural and compositional parameters of
P. falciparum obtained through interpretation of the
measured UV-visible-NIR spectra of DHA treated IRBCs
and parasites extracted from IRBCs
Paramer 10-11 hrs 15-17 hrs
Average cell volume (fl) 10.5 ± 1.3 10.2 ± 2.1
DV volume (fl) 2.9 ± 0.3 3.0 ± 0.3
NU volume (fl) 1.8 ± 0.3 2.0 ± 0.8
HZ (pg/cell) 0.05 ± 0.03 0.04 ± 0.02
Nucleotides in NU (fg/cell) 15 ± 13 14 ± 2
Table 7 Structural and compositional parameters of IRBCs
obtained through interpretation of the measured
UV-visible-NIR spectra of DHA treated cultures
Parmeter 10-11 hrs 15-17 hrs
RBC volume (μm3) 82.9 ± 0.7 89.1 ± 2.2
RBC length (μm) 8.37 ± 0.02 8.26 ± 0.07
RBC width (μm) 2.27 ± 0.02 2.41 ± 0.09
MCHC (g ml-1) 32.6 ± 0.55 30.4 ± 0.9
MCH (pg cell-1) 23.6 ± 0.5 24.1 ± 0.4
MCHI (pg cell
-1) 25.0 ± 0.5 25.3 ± 0.4
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and haemoglobin depletion led to greater discrimination
between the spectral features of control and DHA treated
IRBCs at 15–17 hrs measurement (Figure 4).
Conclusion
A comprehensive spectral interpretation model was devel-
oped in order to extract information on the structure and
composition of the intraerythrocytic parasite and its host
from spectroscopic measurements. Quantitative analysis of
the UV-visible spectra of IRBCs parasitized with the most
lethal malaria parasite P. falciparum allowed insights into
the parasite and host interactions. These results appeared
to be robust when compared to the reported measured
values and estimates made with other methods.
Notable changes occur in the IRBC spectral features
due to reshaping of the infected cells, growth of intracellu-
lar parasites, and depletion of haemoglobin from the host
IRBC cytosol. The spectral interpretation analysis indicated
a mass balance between the total iron in the IRBCs
(haemoglobin in cytosol plus haemozoin in parasites) and
that in healthy RBCs (haemoglobin) indicating no net loss
of iron from IRBCs despite a parasite-induced increase in
the permeability of the IRBC membrane. IRBCs increased
in volume and became more spherical with parasite’s pro-
gression from the ring stage into trophozoite stage. Because
of the parasite’s effort to maintain the osmotic balance and
integrity of the host IRBC, the IRBC volume was less than
a sum of those of a healthy RBC and a parasite at trophozo-
ite stage. This effort included excessive uptake and break
up of haemoglobin [36] followed by the conversion of haem
into haemozoin pigment and removal of free amino acids
and other protein pieces [18,21].
Since spectroscopic measurements have high sensitivity
to the size and composition of particles and cells, the action
of anti-malarial drugs on the structure and composition of
the parasites and IRBCs led to distinguishing spectral
features. Our results demonstrated that the effects of MFQ
and DHA could readily be appreciated at 10–11 hrs after
drug administration. Specifically, MFQ blocked haemozoin
formation and led to the swelling of the parasite’s digestive
vacuole. Since the host IRBC was minimally depleted
in haemoglobin, it increased in volume and changed
shape with parasite’s growth. On the other hand, as
DHA terminated the parasite’s metabolic activity, and
it reduced the sizes of the parasite’s cell body and
organelles. The cell and organelle volumes of DHA
treated parasites were about 60-70% of those of non-
treated parasites grown in parallel as controls. Haemo-
globin depletion from the host cytosol and haemozoin
accumulation discontinued when DHA treatment be-
came effective. These findings suggested that a spectral
interpretation analysis could have significant potential
for drug effect evaluation of parasite isolates or for
therapeutic monitoring of malaria patients.
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